These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)]. Minei-Rachmilewitz T Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270 [TBL] [Abstract][Full Text] [Related]
4. Mefloquine--its 20 years in the Thai Malaria Control Program. Wongsrichanalai C; Prajakwong S; Meshnick SR; Shanks GD; Thimasarn K Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):300-8. PubMed ID: 15691128 [TBL] [Abstract][Full Text] [Related]
5. Drugs for preventing malaria in travellers. Jacquerioz FA; Croft AM Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371 [TBL] [Abstract][Full Text] [Related]
6. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447 [TBL] [Abstract][Full Text] [Related]
7. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
8. The effect of chemoprophylaxis on the timing of onset of falciparum malaria. Reyburn H; Behrens RH; Warhurst D; Bradley D Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928 [TBL] [Abstract][Full Text] [Related]
9. Long-term malaria prophylaxis with weekly mefloquine. Lobel HO; Miani M; Eng T; Bernard KW; Hightower AW; Campbell CC Lancet; 1993 Apr; 341(8849):848-51. PubMed ID: 8096560 [TBL] [Abstract][Full Text] [Related]
10. Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Salako LA; Adio RA; Walker O; Sowunmi A; Stürchler D; Mittelholzer ML; Reber-Liske R; Dickschat U Ann Trop Med Parasitol; 1992 Dec; 86(6):575-81. PubMed ID: 1304698 [TBL] [Abstract][Full Text] [Related]
11. Utilisation of malaria prophylaxis: the effect of changes in guidelines in The Netherlands, 1993-1998. van Riemsdijk MM; Sturkenboom MC; Schilthuis HJ; Stricker BH Pharm World Sci; 2003 Feb; 25(1):21-4. PubMed ID: 12661472 [TBL] [Abstract][Full Text] [Related]
12. Mefloquine to prevent malaria: a systematic review of trials. Croft A; Garner P BMJ; 1997 Nov; 315(7120):1412-6. PubMed ID: 9418088 [TBL] [Abstract][Full Text] [Related]
13. The Italian army standpoint on malaria chemoprophylaxis. Peragallo MS Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658 [TBL] [Abstract][Full Text] [Related]
14. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. Hopperus Buma AP; van Thiel PP; Lobel HO; Ohrt C; van Ameijden EJ; Veltink RL; Tendeloo DC; van Gool T; Green MD; Todd GD; Kyle DE; Kager PA J Infect Dis; 1996 Jun; 173(6):1506-9. PubMed ID: 8648231 [TBL] [Abstract][Full Text] [Related]
15. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand. Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545 [TBL] [Abstract][Full Text] [Related]
16. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial. Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089 [TBL] [Abstract][Full Text] [Related]
17. Mefloquine for malaria chemoprophylaxis 1992-1998: a review. Schlagenhauf P J Travel Med; 1999 Jun; 6(2):122-33. PubMed ID: 10381965 [TBL] [Abstract][Full Text] [Related]
18. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Steketee RW; Wirima JJ; Slutsker L; Khoromana CO; Heymann DL; Breman JG Am J Trop Med Hyg; 1996; 55(1 Suppl):50-6. PubMed ID: 8702037 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan. Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]